Search results for: 'biologicals 2014'

Growth forecasts in 2013 were constantly upgraded or downgraded due to the long-lasting effects of debt in Europe, and stronger performances from the United States and the United Kingdom. Emerging global economies were also beginning to feel the effects of the easing of the US monetary policy; this led to volatility in capital markets globally. For...

This report analyzes the world chemical and biological warfare agent detection markets. The report consists of the following sections: total market overview, executive summary, and three segment chapters focusing on chemical, biological and homeland security niche markets. Total market size is presented along with regional market discussions. In...

The world chemical and biological agent detection market report covers all topics related to this industry. The size of the U.S. market, both military and civilian, is discussed in detail. The world market, which, includes European, Asian, and Middle Eastern markets are also covered. While analyzing the market, the total market size as well as mark...

The world chemical and biological agent detection market report covers all topics related to this industry. The size of the U.S. market, both military and civilian, is discussed in detail. The world market, which, includes European, Asian, and Middle Eastern markets are also covered. While analyzing the market, the total market size as well as mark...

This research service provides insights about the U.S. chemical biological and nuclear detection market.

This study looks at the outcome of the 2018 Strategy which was introduced by the VW Group in 2010. It then analyzes the recent Strategy 2025 which was rolled out by the group. Key aspects of the new strategy are analyzed and their implications for the overall group and the individual brands are discussed. The study also looks at the various capabil...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...